Sofinnova Capital IX 13D and 13G filings for CinCor Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-03 10:06 am Sale | 2023-02-24 | 13D | CinCor Pharma, Inc. CINC | Sofinnova Capital IX | 0 0.000% | -4,220,979 (Position Closed) | Filing |
| 2023-02-13 1:33 pm Purchase | 2023-02-10 | 13D | CinCor Pharma, Inc. CINC | Sofinnova Capital IX | 4,220,979 9.600% | 4,220,979 (New Position) | Filing |